- Home
- ENTG vs ASND Comparison
ENTG vs ASND Comparison
Compare ENTG & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENTG | ASND |
|---|---|---|
| Founded | 1966 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.1B | 13.6B |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ENTG | ASND |
|---|---|---|
| Price | $116.52 | $229.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 15 |
| Target Price | $127.80 | ★ $278.80 |
| AVG Volume (30 Days) | ★ 2.2M | 718.2K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.34% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.55 | N/A |
| Revenue | ★ $3,196,600,000.00 | N/A |
| Revenue This Year | $9.27 | $98.02 |
| Revenue Next Year | $9.39 | $43.13 |
| P/E Ratio | $75.02 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $60.75 | $124.06 |
| 52 Week High | $142.50 | $248.60 |
Technical Indicators
Market Signals| Indicator | ENTG | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 42.28 | 48.04 |
| Support Level | $108.56 | $190.49 |
| Resistance Level | $124.00 | $229.94 |
| Average True Range (ATR) | 5.86 | 9.59 |
| MACD | -3.02 | -0.33 |
| Stochastic Oscillator | 18.08 | 30.82 |
Price Performance
Historical ComparisonAbout ENTG Entegris Inc.
Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.